These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22419632)

  • 21. Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes.
    David S; Gerra D; De Nitti C; Bussolati B; Teatini U; Longhena GR; Guastoni C; Bellotti N; Combarnous F; Tetta C
    Contrib Nephrol; 2003; (138):43-54. PubMed ID: 12463145
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial.
    Sands JJ; Kotanko P; Segal JH; Ho CH; Usvat L; Young A; Carter M; Sergeyeva O; Korth L; Maunsell E; Zhu Y; Krishnan M; Diaz-Buxo JA
    Blood Purif; 2012; 33(1-3):199-204. PubMed ID: 22269855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citrate anticoagulation in the ICU: the Leeds experience.
    Trumper C
    Br J Nurs; 2016 Sep; 25(16):902-6. PubMed ID: 27615524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Efficacy and Safety During Plasma Exchange With Citrate Anticoagulation: A Randomized Study of 4 Versus 15% Citrate.
    Antonic M; Gubensek J; Buturovic-Ponikvar J; Ponikvar R
    Artif Organs; 2016 Apr; 40(4):368-75. PubMed ID: 26365587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.
    Wanner C; Bahner U; Mattern R; Lang D; Passlick-Deetjen J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2570-5. PubMed ID: 15280524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma.
    Marn Pernat A; Medved B; Gubenšek J; Premru V; Knap B; Buturovic-Ponikvar J; Ponikvar R
    Ther Apher Dial; 2016 Jun; 20(3):251-5. PubMed ID: 27312910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic and coagulation effects of citrate: down to the last detail!
    Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD
    Crit Care; 2015 Dec; 19():433. PubMed ID: 26652602
    [No Abstract]   [Full Text] [Related]  

  • 29. Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.
    Brain M; Anderson M; Parkes S; Fowler P
    Crit Care Resusc; 2012 Dec; 14(4):274-82. PubMed ID: 23230876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citrate regional anticoagulation in haemodialysis.
    Hocken AG; Hurst PL
    Nephron; 1987; 46(1):7-10. PubMed ID: 3600914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro investigations of citrate clearance with different dialysis filters.
    Hartmann J; Strobl K; Fichtinger U; Schildböck C; Falkenhagen D
    Int J Artif Organs; 2012 May; 35(5):352-9. PubMed ID: 22466998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Buturović-Ponikvar J; Gubensek J; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Citrate haemodialysis.
    Faber LM; de Vries PM; Oe PL; van der Meulen J; Donker AJ
    Neth J Med; 1990 Dec; 37(5-6):219-24. PubMed ID: 2074914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.
    Brain M; Parkes S; Fowler P; Robertson I; Brown A
    Crit Care Resusc; 2011 Jun; 13(2):72-81. PubMed ID: 21627574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
    Buturović-Ponikvar J; Pernat AM; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
    Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
    Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation.
    Khadzhynov D; Dahlinger A; Schelter C; Peters H; Kindgen-Milles D; Budde K; Lehner LJ; Halleck F; Staeck O; Slowinski T
    Crit Care Med; 2017 Sep; 45(9):e941-e946. PubMed ID: 28538441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of chelated aluminium during haemodialysis using polysulphone high-flux dialysers.
    Aarseth HP; Ganss R
    Nephrol Dial Transplant; 1990; 5(11):942-4. PubMed ID: 2127830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.